Gennova Likely to Submit Data of Phase-I Trial of India's 1st mRNA Vaccine By This Month

Retrieved on: 2021-07-13 16:50:02

Tags for this article:

Click the tags to see associated articles and topics

Gennova Likely to Submit Data of Phase-I Trial of India's 1st mRNA Vaccine By This Month. View article details on hiswai:

Excerpt

Emcure Pharmaceuticals' subsidiary Gennova Biopharmaceuticals will soon be submitting the data of Phase I trials for its mRNA vaccine candidate.

Article found on: www.news18.com